Privia Health Net Profit Margin 2020-2025 | PRVA

Privia Health net profit margin from 2020 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Privia Health Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $1.80B $0.02B 0.83%
2024-12-31 $1.74B $0.01B 0.81%
2024-09-30 $1.72B $0.01B 0.76%
2024-06-30 $1.70B $0.02B 0.88%
2024-03-31 $1.69B $0.02B 1.13%
2023-12-31 $1.66B $0.02B 1.39%
2023-09-30 $1.58B $0.04B 2.41%
2023-06-30 $1.51B $0.03B 2.26%
2023-03-31 $1.43B $0.02B 1.19%
2022-12-31 $1.36B $-0.01B -0.59%
2022-09-30 $1.27B $-0.04B -3.00%
2022-06-30 $1.18B $-0.05B -4.16%
2022-03-31 $1.07B $-0.21B -19.87%
2021-12-31 $0.97B $-0.19B -19.54%
2021-09-30 $0.91B $-0.17B -19.09%
2021-06-30 $0.86B $-0.15B -17.07%
2021-03-31 $0.82B $0.03B 3.79%
2020-12-31 $0.82B $0.03B 3.79%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.989B $1.736B
Privia Health Group Inc. is a technology-driven, physician enablement company which collaborates with medical groups, health plans and health systems to optimize physician practices, improve patient experiences and reward doctors for delivering high-value care in both in-person and virtual settings. Privia Health Group Inc. is based in Arlington, United States.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.174B 54.11
Hims & Hers Health (HIMS) United States $13.701B 142.35
Tempus AI (TEM) United States $10.751B 0.00
IRhythm Technologies (IRTC) United States $4.508B 0.00
Inspire Medical Systems (INSP) United States $4.426B 69.15
Enovis (ENOV) United States $1.969B 10.98
Clover Health Investments (CLOV) United States $1.878B 0.00
Schrodinger (SDGR) United States $1.573B 0.00
Phreesia (PHR) United States $1.516B 0.00
Omnicell (OMCL) United States $1.348B 23.78
Azenta (AZTA) United States $1.294B 60.15
10x Genomics (TXG) United States $1.118B 0.00
Fulgent Genetics (FLGT) United States $0.646B 0.00
Butterfly Network (BFLY) United States $0.566B 0.00
Talkspace (TALK) United States $0.502B 150.00
Veradigm (MDRX) United States $0.476B 0.00
Claritev (CTEV) United States $0.472B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.374B 830.67
Health Catalyst (HCAT) United States $0.274B 0.00
Nyxoah SA (NYXH) Belgium $0.262B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.192B 0.00
EUDA Health Holdings (EUDA) Singapore $0.144B 0.00
Pulmonx (LUNG) United States $0.135B 0.00
American Well (AMWL) United States $0.118B 0.00
MDxHealth SA (MDXH) Belgium $0.102B 0.00
CareCloud (CCLD) United States $0.090B 3.42
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.069B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
Zepp Health (ZEPP) Netherlands $0.039B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.005B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00